Well said Hoskuld. We bake up all kinds of fantasy timelines (myself included) in our minds about Fda meetings when in reality all we need to do is just let it play out, especially at the end of the game. Time slows to a crawl when there is 1 min to go in a college football game. “Time out” after “time out”’is taken to get the final 60 seconds of the game right as there is no “do overs”. Checking what needs to be completed, what needs to be adjusted, and in our case what we need to plan for commercialization wise.
2023 is stacking up pretty good. Time to turn off the monitor and check back in after Anavex sends an email to my “inbox” communicating that ”it is time”.
I agree with everything on your thread. The conclusion of all these communications/efforts would typically result in an SPA defining the path to NDA....it hasn't happened yet (here but it has elsewhere) so once again we have hearsay with ZERO evidence that anything has occurred with the FDA other than "we intend".